Current management decisions in mild cognitive impairment

Clinics in Geriatric Medicine

Volumn 29, Issue 4, 2013, Pages 847-871

  Bensadon, Benjamin A ^a   Odenheimer, Germaine L ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Cognition; Dementia; Impairment; MCI; Memory

Indexed keywords

ALPHA TOCOPHEROL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; DONEPEZIL; EYE DROPS; GALANTAMINE; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEMANTINE; OXYBUTYNIN; PLACEBO; RIVASTIGMINE; SELEGILINE;

ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ANXIETY; CAREGIVER SUPPORT; CLINICAL DECISION MAKING; CLINICAL DEMENTIA RATING; COGNITIVE REHABILITATION; COMORBIDITY; DAILY LIFE ACTIVITY; DEPRESSION; DIFFUSE LEWY BODY DISEASE; DRIVING ABILITY; DRUG FATALITY; DRUG WITHDRAWAL; FINANCIAL MANAGEMENT; FITNESS; FOLLOW UP; GLOBAL DETERIORATION SCALE; HUMAN; INCONTINENCE; LEGAL ASPECT; LIFESTYLE MODIFICATION; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; NUTRITIONAL HEALTH; PATIENT COUNSELING; PSYCHOTHERAPY; QUALITY OF LIFE; RATING SCALE; RECURRENT DISEASE; REVIEW; SELF CARE; SUICIDE; UNSPECIFIED SIDE EFFECT;

COGNITION; DEMENTIA; IMPAIRMENT; MCI; MEMORY;

AGED; CHOLINESTERASE INHIBITORS; HEALTH BEHAVIOR; HUMANS; MILD COGNITIVE IMPAIRMENT; PSYCHOTHERAPY; SELF CARE;

EID: 84884802932     PISSN: 07490690     EISSN: 18798853     Source Type: Journal    
DOI: 10.1016/j.cger.2013.07.008     Document Type: Review

References (144)

1. Rubin E.H., Morris J.C., Grant E.A., et al. Very mild senile dementia of the Alzheimer type: clinical assessment. Arch Neurol 1989, 46(4):379-382.
2. Morris J.C., McKeel D.W., Storandt M., et al. Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 1991, 41(4):469-478.
3. Flicker C., Ferris S.H., Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991, 41(7):1006.
4. Petersen R.C., Smith G.E., Ivnik R.J., et al. Memory function in very early Alzheimer's. Neurology 1994, 44(5):867.
5. Smith G.E., Petersen R.C., Parisi J.E., et al. Definition, course, and outcome of mild cognitive impairment. Aging Neuropsychol Cognit 1996, 3:131-147.
6. Petersen R.C., Smith G.E., Waring S.C., et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999, 56(3):303-308.
7. Morris J.C., Storandt M., Miller J.P., et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001, 58:397-405.
8. Solfrizzi V., Panza F., Colacicco A.M., et al. Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 2004, 63:1882-1991.
9. Larrieu S., Letenneuer L., Orgogozo J.M., et al. Incidence and outcome of mild cognitive impairment in a population-based cohort. Neurology 2002, 59:1594-1599.
10. Roberts R, Geda Y, Knopman D, etal. Men are more likely to have mild cognitive impairment than women: the Mayo Clinic study of aging. Paper presented at the American Academy of Neurology. Chicago, April 12-19, 2008.
11. Perri R., Serra L., Carelsimo G.A., et al. Preclinical dementia: an Italian multicenter study on amnestic mild cognitive impairment. Dement Geriatr Cogn Disord 2007, 23:289-300.
12. Manly J.J., Tang M.X., Schupf N., et al. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol 2008, 63(4):494-506.
13. Petersen R.C., Stevens J.C., Ganguli M., et al. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001, 56:1133-1142.
14. Saxton J., Snitz B.E., Lopez O.L., et al. Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia. JNeurol Neurosurg Psychiatry 2009, 80:737-743.
15. Ganguli M., Dodge H.H., Shen C., et al. Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology 2004, 63:115-121.
16. Perri R., Carlesimo G.A., Serra L., et al. When the amnestic mild cognitive impairment disappears. Cogn Behav Neurol 2009, 22(2):109-116.
17. Peres K., Chrysostome V., Fabrigoule C., et al. Restriction in complex activities of daily living in MCI: impact on outcome. Neurology 2006, 67:461-466.
18. Abner E.L., Kryscio R.J., Cooper G.E., et al. Mild cognitive impairment: statistical models of transition using longitudinal clinical data. Int J Alzheimers Dis 2012, 2012:291920.
19. Winblad B., Palmer K., Kivipelto M., et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. JIntern Med 2004, 256:240-246.
20. Pearman A., Storandt M. Predictors of subjective memory in older adults. JGerontol B Psychol Sci Soc Sci 2004, 59:P4-P6.
21. Lenehan M.E., Klekociuk S.Z., Summers M.J. Absence of a relationship between subjective memory complaint and objective memory impairment (MCI): is it time to abandon subjective memory complaint as an MCI diagnostic criterion?. Int Psychogeriatr 2012, 24(9):1505-1514.
22. Widera E., Steenpass V., Marson D., et al. Finances in the older patient with cognitive impairment: he didn't want me to take over. JAMA 2011, 305(7):698-706.
23. Essig M., Buchem M.A. Degenerative brain disease and aging. Diseases of the brain, head & neck, spine 2012-2015 2012, 58-66. Springer, Milan (Italy). J. Hodler, G.K. von Schulthess, C.H. Zollikofer (Eds.).
24. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. JPsychiatr Res 1975, 12(3):189-198.
25. Ward A., Arrighi H.M., Michels S., et al. Mild cognitive impairment: disparity of incidence and prevalence estimates. Alzheimers Dement 2012, 8:14-21.
26. Albert M.S., DeKosky S.T., Dickson D., et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Ageing-Alzheimer's Association Workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011, 7:270-279.
27. Petersen R.C., Doody R., Kurz A., et al. Current concepts in mild cognitive impairment. Arch Neurol 2001, 58(12):1985-1992.
28. Schneider J.A., Arvanitakis Z., Leurgans S.E., et al. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol 2009, 66:200-208.
29. Galluzzi S., Cimaschi L., Ferrucci L., et al. Mild cognitive impairment: clinical features and review of screening instruments. Aging 2001, 13(3):183-202.
30. Small G.W., Kepe V., Ercoli L.M., et al. PET of brain amyloid and tau in mild cognitive impairment. NEngl J Med 2006, 355:2652-2657.
31. Aizenstein H.J., Nebes R., Saxton J.A., et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 2008, 65:1509-1517.
32. Frisoni G.B., Prestia A., Zanetti O., et al. Markers of Alzheimer's disease in a population attending a memory clinic. Alzheimers Dement 2009, 5(4):307-317.
33. Elias-Sonnenschein L.S., Viechtbauer W., Ramakers I.H., et al. Predictive value of APOE-4 allele for progression from MCI to AD-type dementia: a meta-analysis. JNeurol Neurosurg Psychiatry 2011, 82:1149-1156.
34. Guo L.H., Alexopoulos P., Eisele T., et al. The National Institute on Aging-Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome. Eur Arch Psychiatry Clin Neurosci 2013, 263(4):325-333.
35. Devanand D.P., Folz M., Gorlyn M., et al. Questionable dementia: clinical course and predictors of outcome. JAm Geriatr Soc 1997, 45:321-328.
36. De Jager C., Blackwell A.D., Budge M.M., et al. Predicting cognitive decline in healthy older adults. Am J Geriatr Psychiatry 2005, 13:735-740.
37. Daly E., Zaitchik D., Copeland M., et al. Predicting conversion to Alzheimer's using standardized clinical information. Arch Neurol 2000, 57:675-680.
38. Hanninen T., Hallikainen M., Koivisto K., et al. Afollow-up study of age-associated memory impairment: neuropsychological predictors of dementia. JAm Geriatr Soc 1995, 43:1007-1015.
39. Palmer K., Wang H.Y., Backman L., et al. Differential evolution of cognitive impairment in nondemented older persons: results from the Kungsholmen project. Am J Psychiatry 2002, 159(3):436-442.
40. Wahlund L.O., Pihlstrand E., Jonhagen M.E. Mild cognitive impairment: experience from a memory clinic. Acta Neurol Scand Suppl 2003, 179:21-24.
41. Wolf H., Grunwald M., Ecke G.M., et al. The prognosis of mild cognitive impairment in the elderly. JNeural Transm 1998, 54(Suppl):31-50.
42. Visser P.J., Verhey F.R., Ponds R.W., et al. Course of objective memory impairment in non-demented subjects attending a memory clinic and predictors of outcome. Int J Geriatr Psychiatry 2000, 15:363-372.
43. Gauthier S., Touchon J. Mild cognitive impairment is not a clinical entity and should not be treated. Arch Neurol 2006, 62:1164-1166.
44. Graham J.E., Rockwood K., Beattie B.L., et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997, 349:1793-1796.
45. Di Carlo A., Baldereschi M., Amaducci L., et al. Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability: the Italian longitudinal study on aging. JAm Geriatr Soc 2000, 48:775-782.
46. Martin M., Clare L., Altgassen A.M., et al. Cognition-based interventions for healthy older people and people with mild cognitive impairment. Cochrane Database Syst Rev 2011, (1):CD006220. http://dx.doi.org/10.1002/14651858.CD006220.pub2.
47. Burke W.J., Miller J.P., Rubin E.H., et al. Reliability of the Washington University Clinical Dementia Rating Scale. Arch Neurol 1988, 45(1):31-32.
48. Morris J.C. The clinical dementia rating (CDR): current version and scoring rules. Neurology 1993, 43(11):2412-2414.
49. Reisberg B., Ferris S.H., deLeon M.J., et al. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 1982, 139(9):1136-1139.
50. Schneider J.A., Wilson R.S., Bienias J.L., et al. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 2004, 62:1148-1155.
51. Binswanger O. Die Abgrenzung der allgemeinen progressiven Paralyse. Berl Kli Wochenschr 1894, 31:1180-1186. [in German].
52. Wiederkehr S., Simard M., Fortin C., et al. Comparability of the clinical diagnostic criteria for vascular dementia: a critical review part 1. JNeuropsychiatry Clin Neurosci 2008, 20(2):150-161.
53. Panza F., D'Introno A., Colacicco A.M., et al. Cognitive frailty: predementia syndrome and vascular risk factors. Neurobiol Aging 2006, 27(7):933-940.
54. DiCarlo A., Lamassa M., Baldereschi M., et al. CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia. Neurology 2007, 68:1909-1916.
55. Li J., Wang Y.J., Zhang M., et al. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology 2011, 76(17):1485-1491.
56. Snowdon D.A. Healthy aging and dementia: findings from the nun study. Ann Intern Med 2003, 139:450-454.
57. Snowdon D.A., Grainer L.H., Mortimer J.A., et al. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA 1997, 277:813-817.
58. Zanetti M., Ballabio C., Abbate C., et al. Mild cognitive impairment subtypes and vascular dementia in community-dwelling elderly people: a 3-year follow-up study. JAm Geriatr Soc 2006, 54:580-586.
59. Schneider J.A., Arvanitakis Z., Bang W., et al. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007, 69:2197-2204.
60. Miller J.W., Green R., Ramos M.I., et al. Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2003, 78:441-447.
61. Elias M.F., Sullivan L.M., D'Agostino R.B., et al. Homocysteine and cognitive performance in the Framingham offspring study: age is important. Am J Epidemiol 2005, 162:644-653.
62. Prins N.D., Den Heijer T., Hofman A., et al. Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology 2002, 59:1375-1380.
63. Deschaintre Y., Richard F., Leys D., et al. Treatment of vascular risk factors is associated with slower decline of Alzheimer disease. Neurology 2009, 73(9):674-680.
64. Gorelick P.B., Scuteri A., Black S.E., et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals for the American Heart Association/American Stroke Association. Stroke 2011, 42:2672-2713.
65. Weinstein A.M., Barton C., Ross L., et al. Treatment practices of mild cognitive impairment in California Alzheimer's disease centers. JAm Geriatr Soc 2009, 57(4):686-690.
66. Raschetti R., Albanese E., Vanacore N., et al. Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomized trials. PLoS Med 2007, 4(11):e338.
67. Feldman H.H., Ferris S., Winblad B., et al. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the index study. Lancet Neurol 2007, 6(6):501-512.
68. Petersen R.C., Thomas R.G., Grundman M., et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. NEngl J Med 2005, 352(23):2379-2388.
69. Diniz B.S., Pinto J.A., Gonzaga M.L., et al. To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 2009, 259(4):248-256.
70. Sano M., Ernesto C., Thomas R.G., et al. Acontrolled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. NEngl J Med 1997, 336(17):1216-1222.
71. McShane R., Areosa S.A., Minakaran N. Memantine for dementia. Cochrane Database Syst Rev 2006, (2):CD003154. http://dx.doi.org/10.1002/14651858.CD003154.pub5.
72. Winblad B., Jelic V. Treating the full spectrum of dementia with memantine. Int J Geriatr Psychiatry 2003, 18(S1):S41-S46.
73. Ferris S., Schneider L., Farmer M., et al. Adouble-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI). Int J Geriatr Psychiatry 2007, 22(5):448-455.
74. Posadski P., Ernst E., Lee M.S. Complementary and alternative medicine for Alzheimer's disease: an overview of systematic reviews. Focus Altern Complement Ther 2012, 17(4):186-191.
75. Resnick B., Pacala J.T. 2012 Beers criteria. JAm Geriatr Soc 2012, 60:612-613.
76. McGuinness B., O'Hare J., Craig D., et al. Cochrane review on 'Statins for the treatment of dementia'. Int J Geriatr Psychiatry 2013, 28(2):119-126. http://dx.doi.org/10.1002/gps.3797.
77. Van der Most P.J., Dolga A.M., Nijholt I.M., et al. Statins: mechanisms of neuroprotection. Prog Neurobiol 2009, 88(1):64-75.
78. Sparks D.L. Statins in the treatment of Alzheimer disease. Nat Rev Neurol 2011, 7:662-663. 10.1038/nrneurol.2011.165.
79. Padala K.P., Padala P.R., McNeilly D.P., et al. The effect of HMG-COA reductase inhibitors on cognition in patients with Alzheimer's dementia: a prospective withdrawal and rechallenge pilot study. Am J Geriatr Pharmacother 2012, 10(5):296-302.
80. Evans M.A., Golomb B.A. Statin-associated adverse cognitive effects: survey results from 171 patients. Pharmacotherapy 2009, 29(7):800-811.
81. Wouter Jukema J., Cannon C.P., De Craen A.J., et al. The controversies of Statin therapy: weighing the evidence. JAm Coll Cardiol 2012, 60(10):875-881.
82. Corsentino E.A., Sawyer K., Sachs-Ericsson N., et al. Depressive symptoms moderate the influence of apolipoprotein epsilon4 allele on cognitive decline in a sample of community dwelling older adults. Am J Geriatr Psychiatry 2009, 17(2):155-165.
83. Boyle P.A., Buchman A.S., Barnes L., et al. Effect of a purpose in life on risk of incident Alzheimer disease and mild cognitive impairment in community-dwelling older persons. Arch Gen Psychiatry 2010, 67(3):304-310.
84. Fratiglioni L., Paillard-Borg S., Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol 2004, 3(6):343-353.
85. Bennett D.A., Schneider J.A., Tang Y., et al. The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study. Lancet Neurol 2006, 5(5):406-412.
86. Lindfors P., Lundberg U. Is low cortisol level an indicator of positive health?. Stress Health 2002, 18:153-160.
87. Friedman E.M., Hayney M., Love G.D., et al. Plasma interleukin-6 and soluble il-6 receptors are associated with psychological well-being in aging women. Health Psychol 2007, 26(3):305-313.
88. Willis S.L., Tennstedt S.L., Marsiske M., et al. Long term effects of cognitive training on everyday functional outcomes in older adults. JAMA 2006, 296(23):2805-2814.
89. Kurz A., Pohl C., Ramsenthaler M., et al. Cognitive rehabilitation in patients with mild cognitive impairment. Int J Geriatr Psychiatry 2009, 24:163-168.
90. Ball K., Berch D.B., Helmers K.F., et al. Effects of cognitive training interventions with older adults: a randomized controlled trial. JAMA 2002, 288:2271-2281. Advanced Cognitive Training for Independent and Vital Elderly Study Group.
91. Kurz A.F., Leucht S., Lautenschlager N.T. The clinical significance of cognition-focused interventions for cognitively impaired older adults: a systematic review of randomized controlled trials. Int Psychogeriatr 2011, 1(1):1-12.
92. Belleville S. Cognitive training for persons with mild cognitive impairment. Int Psychogeriatr 2008, 20:57-66.
93. Petersen R.C., Morris J.C. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 2005, 62:1160-1163.
94. Bandura A. Self-efficacy: the exercise of control 1997, WH Freeman, New York.
95. Yalom I.D. The theory and practice of group psychotherapy 1995, Basic Books, New York. 4th edition.
96. Clay O.J., Wadley V.G., Edwards J., et al. The useful field of view as a predictor of driving performance in older adults: a cumulative meta-analysis. Optom Vis Sci 2005, 82:724-731.
97. Anstey K.J., Windsor T.D., Luszcz M.A., et al. Predicting driving cessation over 5years in older adults: psychological well-being and cognitive competence are stronger predictors than physical health. JAm Geriatr Soc 2006, 54:121-126.
98. Ackerman M.A., Edwards J.D., Ross L.A., et al. Examination of cognitive and instrumental functional performance as indicators for driving cessation risk across 3 years. Gerontologist 2008, 48:802-810.
99. Edwards J.D., Ross L.A., Ackerman M., et al. Longitudinal predictors of driving cessation among older adults from the ACTIVE clinical trial. JGerontol B Psychol Sci Soc Sci 2008, 63:P6-P12.
100. Edwards J.D., Myers C., Ross L.A., et al. The longitudinal impact of cognitive speed of processing training on driving mobility. Gerontologist 2009, 49(4):485-494.
101. Teng E., Becker B.W., Woo E., et al. Subtle deficits in instrumental activities of daily living in subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord 2010, 30(3):189-197.
102. Goldberg T.E., Koppel J., Keehlisen L., et al. Performance-based measures of everyday function in mild cognitive impairment. Am J Psychiatry 2010, 167(7):845-853.
103. Hughes T.F., Chang C.C., Bilt J.V., et al. Mild cognitive deficits and everyday functioning among older adults in the community: the Monongahela-Youghiogheny Healthy Aging Team study. Am J Geriatr Psychiatry 2012, 20:836-844.
104. Bangen K.J., Jak A.J., Schiehser D.M., et al. Complex activities of daily living vary by mild cognitive impairment subtype. JInt Neuropsychol Soc 2010, 16(4):630-639.
105. Scogin F., Shah A. Making evidence-based psychological treatments work with older adults 2012, American Psychological Association, Washington, DC.
106. Kramer A.F., Bherer L., Colcombe S.J., et al. Environmental influences on cognitive and brain plasticity during aging. JGerontol A Biol Sci Med Sci 2004, 59(9):M940-M957.
107. Spirduso W.W. Reaction and movement time as a function of age and physical activity level. JGerontol 1975, 30:18-23.
108. Colcombe S., Kramer A.F. Fitness effects on the cognitive function of older adults: a meta analytic study. Psychol Sci 2003, 14:125-130.
109. Marmeleira J.F., Godinho M.B., Fernandes O.M. The effects of an exercise program on several abilities associated with driving performance in older adults. Accid Anal Prev 2009, 41(1):90-97.
110. Morris M.C., Evans D.A., Tangney C.C., et al. Fish consumption and cognitive decline with age in a large community study. Arch Neurol 2005, 62(12):1849-1853.
111. Fotuhi M., Mohassel P., Yaffe K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol 2009, 5(3):140-152.
112. Scarmeas N., Stern Y., Mayeux R., et al. Mediterranean diet and mild cognitive impairment. Arch Neurol 2009, 66:216-225.
113. Piazza-Gardner A.K., Gaffud T.J., Barry A.E. The impact of alcohol on Alzheimer's disease: a systematic review. Aging Ment Health 2012, 17(2):133-146.
114. Solfrizzi V., D'Introno A., Colacicco A.M., et al. Alcohol consumption, mild cognitive impairment, and progression to dementia. Neurology 2007, 68(21):1790-1799.
115. Carpenter B.D., Xiong C., Porensky E.K., et al. Reaction to a dementia diagnosis in individuals with Alzheimer's disease and mild cognitive impairment. JAm Geriatr Soc 2008, 56:405-412.
116. West R.L., Bagwell D.K., Dark-Freudeman A. Self-efficacy and memory aging: the impact of a memory intervention based on self-efficacy. Aging Neuropsychol Cognit 2007, 15:302-329.
117. Bensadon B.A. Self-efficacy and memory aging 2007, [master's thesis], University of Florida, Gainesville (FL).
118. Bensadon B.A. Memory self-efficacy and stereotype effects in aging 2010, [dissertation], University of Florida, Gainesville (FL).
119. Matthews F.E., Stephan B.C., Bond J., Medical Research Council Cognitive Function and Ageing Study, et al. Operationalization of mild cognitive impairment: a graphical approach. PLoS Med 2007, 4:1615-1619.
120. Stephan B.C., Matthews F.E., McKeith I.G., Medical Research Council Cognitive Function and Ageing Study, et al. Early cognitive change in the general population: how do different definitions work?. JAm Geriatr Soc 2007, 55:1534-1540.
121. Stephan B.C., Matthews F.E., Khaw K.T., et al. Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND). Alzheimers Res Ther 2009, 1(1):4.
122. Kane K.D., Yochim B.P., Lichtenberg P.A. Depressive symptoms and cognitive impairment predict all-cause mortality in long-term care residents. Psychol Aging 2010, 25(2):446-452.
123. World Health Organization. Mental health: suicide prevention. World Health Organization Web site. 2013. Available at: Accessed January 8, 2013. http://www.who.int/mental_health/prevention/suicide/suicideprevent/en/.
124. Centers for Disease Control and Prevention. Web-based injury and reporting system. Injury prevention and control: data and statistics (WISQARS). Centers for Disease Control Web site. 2013. Available at: Accessed January 8, 2013. http://www.cdc.gov/injury/wisqars/index.html.
125. Kaplan M.S., McFarland B.H., Huguet N., et al. Suicide risk and precipitating circumstances among young, middle-aged, and older male veterans. Am J Public Health 2012, 102(1):S131-S137.
126. Kellermann A.L., Rivara F.P. Silencing the science on gun research. JAMA 2012, 21:E1-E2.
127. Fiske A., Wetherell J.L., Gatz M. Depression in older adults. Annu Rev Clin Psychol 2009, 5:363-389.
128. Conwell Y., Brent D. Suicide and aging I: patterns of psychiatric diagnosis. Suicide: international perspectives 1996, 15-30. Springer, New York. J.L. Pearson, Y. Conwell (Eds.).
129. McMillan D., Gilbody S., Beresford E., et al. Can we predict suicide and non-fatal self-harm with the Beck Hopelessness Scale? A meta-analysis. Psychol Med 2007, 37:769-778.
130. Joiner T.E., Sachs-Ericsson N.J., Wingate L.R., et al. Perceived burdensomeness and suicidality: two studies on the suicide notes of those attempting and those completing suicide. JSoc Clin Psychol 2002, 21:531-545.
131. Luoma J.B., Martin C.E., Pearson J.L. Contact with mental health and primary care providers before suicide: a review of the evidence. Am J Psychiatry 2002, 159:909-916.
132. Lachs M.S., Pillemer K. Abuse and neglect of elderly persons. NEngl J Med 1995, 332(7):437-443.
133. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. JGen Intern Med 2001, 16(9):606-613.
134. Odenheimer G.L., Hunt L. Functional assessment in geriatric neurology. Clinical neurology of aging 2011, 149-156. Oxford University Press, USA. 3rd edition. M.L. Albert, J.E. Knoefel (Eds.).
135. Vance D.E., Roenker D.L., Cissell G.M., et al. Predictors of driving exposure and avoidance in a field study of older drivers from the state of Maryland. Accid Anal Prev 2006, 38(4):823-831.
136. Lucas-Blaustein M.J., Filipp L., Dungan C., et al. Driving in patients with dementia. JAm Geriatr Soc 1988, 36:1087-1091.
137. Friedland R.P., Koss E., Kumar A., et al. Motor vehicle crashes in dementia of the Alzheimer type. Ann Neurol 1988, 24:782-786.
138. Ball K.K., Roenker D.L., Wadley V.G., et al. Can high-risk older drivers be identified through performance-based measures in a Department of Motor Vehicles setting?. JAm Geriatr Soc 2006, 54(1):77-84.
139. Ross L.A., Clay O.J., Edwards J.D., et al. Do older drivers at risk for crashes modify their driving over time?. JGerontol B Psychol Sci Soc Sci 2009, 64B(2):163-170.
140. Carr D.B., Ott B.R. The older adult driver with cognitive impairment: it's a very frustrating life. JAMA 2000, 303(16):1632-1641.
141. Wadley V.G., Okonkwo O., Crow M., et al. Mild cognitive impairment and everyday function: an investigation of driving performance. JGeriatr Psychiatry Neurol 2009, 22(2):87-94.
142. Francis V., Korsch B.M., Morris M.J. Gaps in doctor-patient communication-patients' response to medical advice. NEngl J Med 1969, 280:535-540.
143. Hall J.A., Roter D.L., Katz N.R. Meta-analysis of correlates of provider behavior in medical encounters. Med Care 1988, 26(7):657-675.
144. Roter D.L., Hall J.A., Merisca R., et al. Effectiveness of interventions to improve patient compliance. Med Care 1998, 36(8):1138-1161.